All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Anti-Cytokine Therapy | NCIT_C15544 | [Drug treatment to reduce the activity of cytokines, particulary to control inflammation in disease modalities.] |
| Colony Stimulating Factor Suppression | NCIT_C40597 | [Any physiologic process which occurs in response to ligation of a colony stimulating factor receptor with a cognate ligand, and results in a reduced number of active signaling molecules within the target cell. This process is involved in regulating the extent of the response to receptor binding, and in regulating active populations of macrophages, granulocytes and myeloid cells.] |
| Colony Stimulating Factor Signaling Process | NCIT_C40585 | [Any process which promotes expression of colony stimulating factors, their subsequent secretion, binding to their cognate receptors or intracellular signaling, and results in proliferation and differentiation of the target cell. This process is involved in regulating active populations of macrophages, granulocytes and myeloid cells.] |
| Interferon Suppression | NCIT_C40598 | [Any therapeutic or preventive precedure that involves inhibition of the production or activity of an interferon. This process may result also in inhibition of some functions of mature immune cells, including polymorphonuclear chemotaxis and monocyte phagocytosis. Interferon suppression is intended to favorably modulate functions of the immune system.] |
| Biological Therapy | NCIT_C15187 | [A type of treatment that uses substances derived from or made by living organisms to treat disease; this includes both naturally occurring and synthetic products.] |
| Negative Regulation of Interleukin Signaling | NCIT_C40599 | [Any physiologic process which occurs in response to ligation of an interleukin receptor with a cognate ligand, and results in a reduced number of active signaling molecules within the target cell. This process is involved in regulating the extent of the extent of the response to receptor binding, and in regulating active populations of T, B and hemopoietic cells.] |
| Interleukin Signaling Process | NCIT_C40588 | [Any process which promotes expression of the interleukin proteins, their secretion, receptor binding or intracellular signaling, and promotes proliferation and differentiation among target populations, inflammation, chemotaxis, production of antibodies and modulation of further cytokine expression. This process is involved in regulating active populations of leukocytes and coordinating systemic responses to pathogenic infection.] |
| Intralobar Nephrogenic Rest | NCIT_C88540 | [A nephrogenic rest found within the renal lobe.] |
| Hemihypertrophy | NCIT_C88541 | [A finding indicating the presence of greater than normal asymmetry between the right and left sides of the body. The asymmetry may be manifested in the entire side or part of it.] |
| Abnormal Finding | NCIT_C82547 | [A decision that an observation or result is outside the parameters considered normal.] |
| Merkel Cell Carcinoma Clinical Regional Lymph Nodes TNM Finding v7 | NCIT_C88542 | [A clinical finding about one or more characteristics of Merkel cell carcinoma, following the rules of the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes. The TNM clinical and pathologic regional lymph nodes classifications of Merkel cell carcinoma are not the same. TNM clinical regional lymph nodes findings are based on clinical inspection and palpation of the regional lymph nodes and/or radiologic studies. (from AJCC 7th Ed.)] |
| Merkel Cell Carcinoma Pathologic Regional Lymph Nodes TNM Finding v7 | NCIT_C88525 | [A pathologic finding about one or more characteristics of Merkel cell carcinoma, following the rules of the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes. The TNM pathologic and clinical regional lymph nodes classifications of Merkel cell carcinoma are not the same. TNM pathologic regional lymph nodes findings are based on the histologic examination of the regional lymph nodes, following focused (sentinel lymph node biopsy), therapeutic, or complete lymphadenectomy. (from AJCC 7th Ed.)] |
| Merkel Cell Carcinoma pNX TNM Finding v7 | NCIT_C88526 | [Merkel cell carcinoma in which the regional lymph nodes cannot be assessed. (from AJCC 7th Ed.)] |
| Merkel Cell Carcinoma pN0 TNM Finding v7 | NCIT_C88527 | [Merkel cell carcinoma with negative regional lymph nodes by pathologic examination. (from AJCC 7th Ed.)] |
| Merkel Cell Carcinoma pN1 TNM Finding v7 | NCIT_C88528 | [Merkel cell carcinoma with metastasis in regional lymph node(s). (from AJCC 7th Ed.)] |
| NPPB wt Allele | NCIT_C88521 | [Human NPPB wild-type allele is located in the vicinity of 1p36.2 and is approximately 1 kb in length. This allele, which encodes natriuretic peptides B, plays a role in diuresis, vasorelaxation and regulation of renin and aldosterone secretion.] |
| NPPB Gene | NCIT_C88520 | [This gene is involved in cardiac homeostasis.] |
| 1p36.2 | NCIT_C38888 | [A chromosome band present on 1p] |
| Natriuretic Peptides B | NCIT_C88522 | [Natriuretic peptides B (134 aa, ~15 kDa) is encoded by the human NPPB gene. This protein is involved in the maintenance of cardiac homeostasis.] |
| NPPB Gene Product | NCIT_C113693 | [A protein encoded by the NPPB gene.] |